# Thyroid Function of Pediatric Subjects Following Isovue® Administration

> **NCT03779906** · PHASE4 · TERMINATED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 17 (actual)

## Conditions studied

- Hypothyroidism

## Interventions

- **DRUG:** Isovue

## Key facts

- **NCT ID:** NCT03779906
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-26
- **Primary completion:** 2021-11-15
- **Final completion:** 2022-03-25
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Formal release from PMR
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779906, "Thyroid Function of Pediatric Subjects Following Isovue® Administration". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03779906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*